Skip to main content

INVESTING IN INNOVATION

Commercialising world class research from UCL

£0M

HAS been invested in UCL projects

0

Proof of concept projects

0

Spinouts

0

Funding for licensing projects

Quell Therapeutics makes FierceBiotech's 2019 Fierce 15

Echopoint raises £2.8m to address the ‘grey zone’ of heart disease treatment

Achilles Therapeutics raises £100m in Series B

Portfolio company Astroscreen featured in the Evening Standard

Why we Invested in Quantum Computing start-up Phasecraft

Orchard Therapeutics Announces Update from POC Study of OTL-203